Back to results
US 2006/0233803 A1Published application
Use of A33 antigens and JAM-it
AssigneeGenentech, Inc.
InventorsAvi Ashkenazi, Sherman Fong, Audrey Goddard, Austin Gurney, Mary Napier, Daniel Tumas, Menno Lookeren, William Wood
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer.
Claims7
A method of treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO:
- 32 in a mammal, comprising administering to said mammal an effective amount of an immunoadhesin comprising an extracellular domain sequence of the polypeptide of SEQ ID NO:
- 32, whereby said inflammatory disease is treated.
Dependencies are inferred from the claim text.